Company Info
Phone(781) 895-0600
Year Established
1981
Ticker
ABBV
Exchange
NYSE
Contacts
Mark EnyedyPresident & CEO
Daniel Char, JD
CLO
Lauren White
CFO
Stacy Coen
CBO
Isabel Kalofonos
CCO
Company Description
ImmunoGen, an AbbVi company, is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
